Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence

2011 ◽  
Vol 204 (10) ◽  
pp. 536-540 ◽  
Author(s):  
Li Bie ◽  
Gang Zhao ◽  
Yan Ju ◽  
Bo Zhang
2008 ◽  
Vol 1 (1) ◽  
Author(s):  
Leela Reddy ◽  
Timothy L. Friesen ◽  
Steven W. Meinhardt ◽  
Shiaoman Chao ◽  
Justin D. Faris

2007 ◽  
Vol 8 (1) ◽  
Author(s):  
Jennifer L Ingram ◽  
Aurita Antao-Menezes ◽  
Elizabeth A Turpin ◽  
Duncan G Wallace ◽  
James B Mangum ◽  
...  

Neurology ◽  
2022 ◽  
pp. 10.1212/WNL.0000000000013278
Author(s):  
Agatha Schlüter ◽  
Agustí Rodríguez-Palmero ◽  
Edgard Verdura ◽  
Valentina Vélez-Santamaría ◽  
Montserrat Ruiz ◽  
...  

Background and Objectives:Genetic white matter disorders (GWMD) are of heterogeneous origin, with more than a hundred causal genes identified to date. Classical targeted approaches achieve a molecular diagnosis in only half of all patients. Here we aim to determine the clinical utility of singleton whole-exome sequencing and whole-genome sequencing (sWES-WGS) interpreted with a phenotype- and interactome-driven prioritization algorithm to diagnose GWMD patients, while identifying novel phenotypes and candidate genes.Methods:A case series of patients of all ages with undiagnosed GWMD despite extensive standard-of-care paraclinical studies were recruited between April 2017 and December 2019 in a collaborative study at the Bellvitge Biomedical Research Institute (IDIBELL) and neurology units of tertiary Spanish hospitals. We ran sWES and WGS and applied our interactome-prioritization algorithm, based on the network expansion of a seed group of GWMD-related genes, derived from the HPO terms of each patient.Results:We received 126 patients (101 children and 25 adults), with ages ranging from 1 month to 74 years. We obtained a first molecular diagnosis by singleton WES in 59% of cases, which increased to 68% after annual reanalysis and reached 72% after WGS was performed in 16 of the remaining negative cases. We identified variants in 57 different genes among 91 diagnosed cases, with the most frequent being RNASEH2B, EIF2B5, POLR3A and PLP1; and a dual diagnosis underlying complex phenotypes in six families, underscoring the importance of genomic analysis to solve these cases. Finally, we discovered 9 candidate genes causing novel diseases, and propose additional putative novel candidate genes for yet-to-be discovered GWMD.Discussion:Our strategy enables a high diagnostic yield and is a good alternative to trio WES/WGS for GWMD. It shortens the time to diagnosis compared to the classical targeted approach, thus optimizing appropriate management. Furthermore, the interactome-driven prioritization pipeline enables the discovery of novel disease-causing genes and phenotypes, and predicts novel putative candidate genes, shedding light on etiopathogenic mechanisms that are pivotal for myelin generation and maintenance.


BMC Genomics ◽  
2015 ◽  
Vol 16 (1) ◽  
Author(s):  
Florent Ailloud ◽  
Tiffany Lowe ◽  
Gilles Cellier ◽  
David Roche ◽  
Caitilyn Allen ◽  
...  

2016 ◽  
Vol 103 (1) ◽  
pp. 33-46 ◽  
Author(s):  
Victoria L. Sork ◽  
Kevin Squire ◽  
Paul F. Gugger ◽  
Stephanie E. Steele ◽  
Eric D. Levy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document